Two major forms of phospholipase D (PLD) activity, solubilized from rat brain membranes with Triton X-100, were separated by HPLC on a heparin-SPW column with buffer containing octyl glucoside. One form was completely dependent on sodium oleate for activity. The other, which was dramatically activated by the addition of ADPribosylation factor (ARF) 1 and guanine 5' [y-thio] (14, 15) . The cytosolic factors were purified and identified as ADP-ribosylation factor 1 (ARF1) and/or ARF3, which stimulated PLD activity from HL-60 cell membranes in the presence of GTP[yS] (20, 24) . These ARFs are ==20-kDa proteins initially identified as activators of cholera toxin ADP-ribosyltransferase activity (25) (27) .
Phospholipase D (PLD) catalyzes the hydrolysis ofphosphatidylcholine (PtdCho), producing phosphatidic acid (PtdOH) and choline (for review, see ref. 1) . PtdOH is a central metabolite in both phospholipid and triglyceride metabolism and an effector in several physiological processes including secretion, DNA synthesis, and cell proliferation. PtdOH is metabolized by PtdOH phosphohydrolase to diacylglycerol, which can activate protein kinase C. Thus, PLD action generates not only PtdOH, a molecule with potential secondmessenger functions, but also the well known secondmessenger diacylglycerol, and is a major source of both. PLD activity was first identified in plants (2) and then in bacteria and fungi (3) . Its presence in mammalian tissues was reported in 1973 (4) . PtdCho-preferring PLD has been found in numerous tissues and cells-including brain, lung, liver, adipose tissue, endothelial cells, HL-60 cells, and spermatozoa; lung and brain are the richest sources (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
Membrane-associated PLD activities appear specific for PtdCho (16) (17) (18) , whereas cytosolic forms hydrolyze phosphatidylethanolamine (PtdEtn) and phosphatidylinositol (PtdIns) , as well as PtdCho (17, 18) . PLD activities partially purified from rat brain (19) and HL-60 cells (20) were associated primarily with particulate fractions. PLD has not been purified to homogeneity, and its subcellular localization remains to be definitively identified. It is possible that the enzyme can be present in membranes as well as in the cytosol, as shown for phospholipase C isozymes (21) . Liscovitch and coworkers (12, 22) described membrane-bound PLD activity that was absolutely dependent on sodium oleate and was markedly activated by Mg2+ and Ca2+. Under those assay conditions with exogenous PtdCho as a substrate, activity ofthe membrane-bound PLD was not affected by the addition of GTP analogues (12, 18) (6, 23) and HL-60 cells (14, 15) . The cytosolic factors were purified and identified as ADP-ribosylation factor 1 (ARF1) and/or ARF3, which stimulated PLD activity from HL-60 cell membranes in the presence of GTP[yS] (20, 24) . These ARFs are ==20-kDa proteins initially identified as activators of cholera toxin ADP-ribosyltransferase activity (25) and are now known to play a critical role in vesicular membrane trafficking in all eukaryotic cells (26) . We report here the separation, after solubilization from rat brain membranes, of Chromatography of Rat Brain PLD. All procedures were done at 40C. Rat brains were homogenized in 10 vol (wt/vol) of homogenization buffer (20 mM Hepes, pH 7.0/1 mM EGTA/1 mM EDTA/0.1 mM dithiothreitol/2 mM phenylmethylsulfonyl fluoride) two or three times for 1 min at maximum speed with a Polytron homogenizer (Brinkmann). The homogenate was centrifuged (1000 x g, 20 min), and the supernatant was centrifuged (100,000 x g, 1 hr). Pelleted membranes from this centrifugation were extracted for 1 hr with homogenization buffer containing 0.5% Triton X-100 (volume equal to twice the initial weight of tissue, ml/g). Insoluble material was discarded after centrifugation (100,000 x g, 1 hr) leaving solubilized membrane proteins (8-10 mg/ml).
Solubilized proteins (4 g) from 200 g of rat brain were applied (flow rate, 20 ml/min) to a column (50 x 150 mm) of heparin-Sepharose CL-6B (Pharmacia) equilibrated in 20 mM Hepes, pH 7.0/1 mM EGTA/1 mM EDTA/0.1 mM dithiothreitol/0.7% octyl PfiD-glucopyranoside followed by 400 ml of equilibration buffer. Proteins were eluted with a linear gradient of 0-1.5 M NaCl in a total volume of 2 liters of equilibration buffer (20 ml/min). Fractions (20 ml) were collected, and samples (5 /l4) were assayed for ARFdependent and oleate-dependent hydrolysis of PtdCho (Fig.  1A) .
Complete separation of ARF-dependent and oleatedependent activities by HPLC was achieved by applying 30 mg of solubilized membrane proteins to a Tosohaas heparin-SPW column (7.5 x 75 mm) equilibrated in 20 mM Hepes, pH 7.0/1 mM EGTA/1 mM EDTA/0.1 mM dithiothreitol/0.7% octyl-3-D-glycopyranoside. Proteins were eluted (flow rate, 1 ml/min) with equilibration buffer for 10 min, followed by a linear gradient from 0 to 0.5 M NaCl in 15 min, 0.5 M NaCl for a further 20 min, a second linear gradient from 0.5 to 1 M NaCl in 5 min, and equilibration buffer containing 1 M NaCl for 30 min. Fractions (1 ml) were collected and assayed for ARF-dependent and oleate-dependent activities (Fig. 1B) . Oleate-dependent activity was assayed by a slight modification of a published procedure (12 7.5) . After incubation at 37°C as indicated, tubes were transferred to an ice bath, and 1 ml of chloroform/methanol/ concentrated HC1, 50:50:0.3 (vol/vol), was added followed by 0.3 ml of 1 M HC1/5 mM EGTA. Tubes were centrifuged as described above and 500-,u samples of supernatant were collected for radioassay.
Preparation of Recombinant ARF (rARF) Proteins. rARFl (28) and rARF5 and mARF5 (29) were prepared and purified by published procedures, except that lysozyme (10 mg/ml) and sonification were used to disrupt the Escherichia coli. rARF6 was prepared as described by Price et al. (30) , except that the ARF6 cDNA was subcloned into the pT7/ Nde expression vector, as described by Hong et al. (28) . Coexpression of plasmids containing human ARF-coding sequences with a vector containing N-myristoyltransferase (pAcYC177/ET3d/yNMT) (29) produced myristoylated forms of rARF1, rARF5, and rARF6, designated mARF1, mARF5, and mARF6, respectively. The cytosol was applied to a column of Ultrogel AcA 54 (Sepracore, Marlborough, MA), which was eluted with buffer B. Fractions containing ARF activity were pooled and stored at -20°C. Protein concentrations were determined by the Bio-Rad assay. ARF preparations were usually >90% pure, as judged by Coomassie staining of samples (-5-10 pg) after SDS/PAGE.
RESULTS AND DISCUSSION
Separation of Rat Brain Oleate-and ARE-Dependent PLD Activities. When the Triton X-100 extract of rat brain membranes was fractionated on a heparin-Sepharose column, activity that was eluted at 0.4 M NaCl (peak I) was identified in assays with 4 mM sodium oleate. Additional PLD activity (peak II) that could not be detected in the presence of oleate was found with assays containing mARFi and GTP[-yS] (Fig.  1A) . These two activities, which are referred to as "oleatedependent PLD" and "ARF-dependent PLD," were separated completely using the heparin-SPW HPLC with combined linear and stepwise gradients of NaCl (Fig. 1B) .
To confirm that both oleate-and ARF-dependent activities were due to PLD, phosphatidylethanol (PtdEtOH) formation by the two forms ofPLD under their optimal assay conditions was monitored. In fractions from heparin-5PW HPLC, PtdEtOH generation corresponded with both peaks of PLD activity identified in the [3H]choline release assays (Fig. 1C) . PtdEtOH and PtdOH are, respectively, the products of the transphosphatidylation and hydrolytic reactions catalyzed by PLD. Because PtdEtOH is exclusively a product of PLD (31) (32) (33) and is relatively stable metabolically (32, 33) , it is a reliable indicator ofPLD activity, whereas release of 3H from [methyl-3H]phosphatidylcholine in a water-soluble form could result also from phospholipase C activity.
Properties of Rat Brain Oleate-and ARF-Dependent PLD Activities. Oleate-dependent PLD activity was maximal with 4 mM sodium oleate but was %50% less with 8 mM; 0.3 mM sodium oleate completely inhibited ARF-dependent PLD ( Fig. 2A) Oleate With ARF-dependent PLD fractions from heparinSepharose CL-6B chromatography, addition of mARF1 after 30 or 60 min of incubation produced essentially the same marked stimulation as it did when added at zero time (Fig. 3) . Thus, the PLD seemed to be stable for at least 90 min under assay conditions. With a 60-min incubation period, PtdCho hydrolysis was proportional to the amount of PLD added over only a relatively narrow range (data not shown), probably due to the crude nature of the enzyme preparation.
ARFi (and ARF3), which have been described as activators of PLD in HL-60 cells (20, 24) are class I ARFs that are ubiquitous in eukaryotic cells and have been implicated in vesicular membrane trafficking in the secretory pathway (26) . The function(s) of class II and III ARFs, identified by cDNA cloning, is less well understood (34) , and it seemed important to determine whether they also are capable of activating PLD. ARF5 was used as a representative of class II, and ARF6 was used as a representative of class IH. mARF5 and mARF6 were similarly effective in stimulating PLD activity, whereas somewhat larger amounts of mAREl were apparently required to achieve comparable activation (Fig. 4) . The significance of these differences cannot, however, be evaluated precisely, as it is not known just what fractions of the ARF proteins were, in fact, myristoylated. In addition, some ARFs may be isolated with bound GTP (35) , and in the preparations used here, the amounts of GTP-liganded ARF were not known. The maximal effect of mARF6 was not defined because the concentration of the ARF preparation made it impossible to achieve >0. in coatomer binding and bud formation? Or does PLD activity participate in the last step of this kind of process, when the transport vesicle fuses with the target membrane?
